Ploussard, Guillaume http://orcid.org/0000-0002-6004-2152
Rozet, François
Roubaud, Guilhem
Stanbury, Trevor
Sargos, Paul
Roupret, Morgan
Funding for this research was provided by:
Thermo Fisher Scientific
Article History
Received: 16 November 2022
Accepted: 5 December 2022
First Online: 17 December 2022
Declarations
:
: GP has received consulting fees from Thermo Fisher, Janssen, Astellas, Ferring, Ipsen, AstraZeneca, Pfizer, and MSD. FR has received research funding, consultation fees, payments/honoraria, support for travelling and conferences, either directly or for his institution, from Astellas, AstraZeneca, Bayer, Ipsen, Janssen, and Leo pharma. GR has received research funding, consultation fees, payments/honoraria, support for travelling and conferences, either directly or for his institution, from Astellas, AstraZeneca, Bayer, Gilead, Ipsen, Janssen, Pfizer, Sanofi, and Thermo Fisher. TS received payment for medical writing services from Thermo Fisher. PS has received consulting fees from Thermo Fisher. MR has received consulting fees from Astellas, Bristol Myers Squibb, IPSEN, Janssen, and Thermo Fisher.
: The manuscript is a review of the literature and did not involve humans nor animals.
: Not applicable.